Brazil study suggests AstraZeneca vaccine is effective against Brazil COVID-19 variant

Brazil study suggests AstraZeneca vaccine is effective against Brazil COVID-19 variant
  • Clock-gray 00:31
  • calendar-gray 09 March 2021

Preliminary studies suggest the AstraZeneca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil’s Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday, APA reports quoting Reuters.

The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from the Latin American nation.

apa-logo-mini

Other news